Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin, Doxorubicin and Tamoxifen (CAT) for Incurable Malignancies
NCT00002608Phase 2Completed
- Sponsor
- The Ottawa Hospital Cancer Centre
- Start
- May 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in soft tissue sarcoma (STS), glioma, malignant mesothelioma, liver cancer, thyroid cancer, sponsored by The Ottawa Hospital Cancer Centre. Started May 1994; status: completed.
02
Drugs
tamoxifen
03
Conditions
soft tissue sarcoma (STS)gliomamalignant mesotheliomaliver cancerthyroid cancer
Beyond the preview
Go deeper on NCT00002608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002608.